Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission

por Stuckey, Ruth, López Rodríguez, Juan Francisco, Gómez-Casares, María Teresa
Publicado 2022

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

por Stuckey, Ruth, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, Segura-Díaz, Adrián, Sánchez-Farías, Nuria, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Publicado 2020

Additional evidence that the rat renal interstitium contracts in vivo

por Rodríguez-Martínez, Manuel, López-Rodríguez, Juan Francisco, Flores-Sandoval, Omar, Calvo-Turrubiartes, Miriam Zarahí, Sánchez-Briones, María Eugenia, Silva-Ramírez, Ana Sonia, Guerreo-Ojeda, Vianney
Publicado 2019

Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment

por Stuckey, Ruth, Segura-Díaz, Adrián, Sáez Perdomo, María Nieves, Pérez Encinas, Manuel Mateo, González San Miguel, Jóse David, Florido, Yanira, Sánchez-Sosa, Santiago, López-Rodríguez, Juan Francisco, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Publicado 2023

Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations

por Segura-Díaz, Adrián, Stuckey, Ruth, Florido, Yanira, González-Martín, Jesús María, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, González-Pérez, Elena, Perdomo, María Nieves Sáez, Perera, María del Mar, de la Iglesia, Silvia, Molero-Labarta, Teresa, Gómez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Publicado 2020